Sanofi-Aventis airs Ambien CR TV ads, coupon

Share this article:
Sanofi-Aventis' DTC campaign for Ambien CR (zolpidem tartrate extended release) began this month with a pair of television commercials--including a TV reminder ad--and a coupon for a free seven-day trial.
The 15-second reminder ad ran its course before Sanofi-Aventis introduced the longer spot, a spokesperson said. TV reminder ads are banned under the PhRMA DTC guidelines, which go into effect Jan. 1.
Among the scenes in the 60-second spot is one showing the multi-layered pill's first layer dissolving in a fizz of green 'Z's followed by the second only more slowly. That scene is followed by one of a woman waking up, looking well rested and vigorously going about her morning routine. A voiceover presents risk and safety information before the narrator concludes with the tagline, "Tomorrow will thank you."
The coupon, which ran in mixed media, offers a seven-day free trial of Ambien CR and appears to contain no indication or risk information.
Ambien CR gained approval in September, and Sanofi-Aventis launched to doctors in October.
Sanofi-Aventis, which faces patent expiration on original Ambien next year, aims to switch at least half of patients to the new formulation.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.